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Abstract
Background: Palm oil’s high yields, consequent low cost and highly versatile properties as a cooking oil and food
ingredient have resulted in its thorough infiltration of the food sector in some countries. Longitudinal studies have
associated palm oil’s high saturated fatty acid content with non-communicable disease, but neither the economic
or disease burdens have been assessed previously.
Methods: This novel palm oil-focussed disease burden assessment employs a fully integrated health,
macroeconomic and demographic Computable General Equilibrium Model for Thailand with nine regional (urban/
rural) households. Nutritional changes from food consumption are endogenously translated into health (myocardial
infarction (MI) and stroke) and population outcomes and are fed back into the macroeconomic model as health
and caregiver-related productive labour supply effects and healthcare costs to generate holistic 2016–2035 burden
estimates. Model scenarios mirror the replacement of palm cooking oil with other dietary oils and are compared
with simulated total Thai health and macroeconomic burdens for MI and stroke.
Results: Replacing consumption of palm cooking oil with other dietary oils could reduce MI/stroke incident cases
by 8280/2639 and cumulative deaths by 4683/894 over 20 years, removing approximately 0.5% of the total Thai
burden of MI/stroke. This palm cooking oil replacement would reduce consumption shares of saturated/
monounsaturated fatty acids in Thai household consumption by 6.5%/3% and increase polyunsaturated fatty acid
consumption shares by 14%, yielding a 1.74% decrease in the population-wide total-to-HDL cholesterol ratio after
20 years. The macroeconomic burden that would be removed is US$308mn, approximately 0.44% of the total
burden of MI/stroke on Thailand’s economy or 0.003% of cumulative 20-year GDP. Bangkok and Central region
households benefit most from removal of disease burdens.
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Conclusions: Simulations indicate that consumption of palm cooking oil, rather than other dietary oils, imposes a
negative health burden (MI and stroke) and associated economic burden on a high consuming country, such as
Thailand. Integrated sectoral model frameworks to assess these burdens are possible, and burden estimates from
our simulated direct replacement of palm cooking oil indicate that using these frameworks both for broader
analyses of dietary palm oil use and total burden analyses of other diseases may also be beneficial.
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Background
Vegetable oils are a major component of food systems and
an important economic commodity. Since 1980, the global
use of vegetable oils has increased by a factor of 4.5. In par-
ticular, due to its proportionally high yields [1], palm oil
consumption has grown tenfold since 1980, exceeding that
of soybean oil and constitutes around one-third of global
vegetable oil consumption (57 million tonnes) [2], three-
quarters of which is used for food. Palm oil’s pervasive use
throughout food systems derives from its high yields and
consequent low price amongst dietary oils but also from its
versatility: its stability makes it ideal for frying purposes and
its texture and oxidisability make it useful as a processed
food ingredient and give it preservative properties [3]. How-
ever, palm oil contains a very high ratio of saturated fatty
acids (SFA) to polyunsaturated fatty acids (PUFA) and
monounsaturated fatty acids (MUFA) and increased con-
sumption of SFAs relative to MUFA and PUFA has been
linked to increases in serum cholesterol [4, 5] and, in turn,
to increased incidence and mortality of myocardial infarc-
tion (MI) and stroke [6] and, more broadly, to increased
rates of death from cardiovascular disease [7]. These diverse
properties therefore place palm oil at the intersection
between economic, health and nutritional policy interests.
Recent rapid increases in production and consumption of
palm oil are expected to continue, potentially increasing as-
sociated burdens of non-communicable disease, and this has
led to recommendations that future long-term palm oil
strategies should incorporate both economic interests and
population health benefits [8]. However, the size of palm
oil’s contribution to disease burdens and its economic im-
pact are largely unknown and no macroeconomic and
health burden estimates exist to quantify combined eco-
nomic, disease burden and population impacts alongside
other policy perspectives. This computable general equilib-
rium (CGE) analysis aims to fill this gap by providing an in-
tegrated quantification of the combined macroeconomic,
disease and population burden of palm cooking oil con-
sumption in a major palm oil consuming country context,
Thailand.
Palm oil’s effect on health
Palm oil is made up from 40 to 50% SFAs [9], and has
the highest saturated fat content of vegetable oils,
commonly used in cooking and food production, except
for coconut oil [10]. Increased saturated fat consumption
is thought to increase serum cholesterol [4, 5] and in-
crease rates of death from cardiovascular disease [7], but
the relationship between dietary oils, saturated fat and
health is complex. Historical longitudinal studies have
shown that replacement of saturated fats with polyunsat-
urated or monounsaturated fats produces a substantive
and statistically significant reduction in cardiovascular
risk from MI and stroke [11–13]. While some recent evi-
dence has questioned the relationship between SFA in-
take and clinical health outcomes [14, 15], other
compelling evidence supports the replacement of satu-
rated fat with unsaturated fats and affirms the link be-
tween changes in palm oil consumption, serum
cholesterol and incidence and mortality of MI and stroke
[16, 17]. It has been suggested that palmitic acid (the
saturated fatty acid which makes up 35–45% of palm oil
fatty acids) has little effect on the lipid profile of individ-
uals [18], but this stands in contrast to other evidence
that palm oil consumption results in higher LDL choles-
terol than do vegetable oils low in saturated fat [6, 9].
There is also strong evidence from large-scale longitu-
dinal studies, conducted over 24–28 years, showing that
replacement of saturated lauric, myristic and stearic acid
yields a 6–8% reduced risk of coronary heart disease,
while replacement of palmitic acids yields a larger 10–
12% reduction in risk [19]. Current long-term results
therefore present convincing evidence for the health
benefits of replacing saturated fats from palm oil with
poly- and monounsaturated fats and support the
methods presented in Mensink et al. [4]. These methods
are particularly applicable in analyses of the type pre-
sented here which focus on the pure nutritional effect of
consuming palm cooking oil relative to other dietary oils
and they are therefore the basis for the health modelling
underlying our disease burden estimations.
The usefulness of palm oil for food
Palm oil’s properties relative to alternative vegetable oils
have been summarised elsewhere [3] and, in addition to
wide availability and low cost, include suitability and su-
periority both as a frying oil and for a wide range of
processed food applications. It is low in harmful trans
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fatty acids but its stability and oxidative properties result
in a longer shelf life for foods that contain it. However,
many of the properties of palm oil which are beneficial
for use in food are derived from its very high saturated
fat content. Replacing palm oil in food processing appli-
cations such as bakery and confectionery products is
costly and complex in terms of practical implementation.
However, replacement of palm oil in applications which
involve small amounts of fat and replacement of palm
oil with other liquid oils for domestic frying purposes is
more feasible [20]. Therefore, focussing on palm cooking
oil and estimating the nutritional and disease burden ef-
fects which result from its consumption by households
is preferable for our modelling of economic commodities
and nutritional impacts.
Country context
In many countries, palm oil is the predominant cooking
oil and the cheapest oil for food use. In countries with a
comparative advantage in palm oil production, yields per
hectare of land can be ten times that of soybean oil [1]. In
Thailand, the world’s third largest producer [21] and the
context for this study, the production and availability of
palm oil in the domestic market is high constituting 36%
of the vegetable oil supply at 7.5 g/capita/day [22], and it
is used in a wide range of foods. Since Thailand’s future
plans for palm oil sector development include production
for domestic use, with a focus on self-sufficiency and food
security [23], and proposals to expand future palm planta-
tion areas by 40%, increase oil extraction rates by 10% and
encourage growth in consumption by 3% p.a. [21], it is an
ideal context to conduct this assessment of macroeco-
nomic and health burdens of palm cooking oil
consumption.
What is known about the economic and health burdens
of palm oil?
Few studies have quantified the specific burden on health
and health costs of palm oil consumption. Health studies
have used logistic regressions to show that switching from
palm to soybean consumption in Costa-Rica would reduce
the burden of MI [24], while linear panel regressions have
linked increased palm oil consumption to higher ischemic
heart disease mortality rates in developing countries [25].
An economic-epidemiologic model has also been applied
to simulate the effects of food taxation of palm oil con-
sumption in India [6]. Furthermore, the World Health Or-
ganisation has referred to the link between palmitic acid
consumption and cardiovascular disease as ‘convincing’
[26], but the disease burden, attributable to palm oil, re-
mains to be quantified.
Economic studies exclude health but have linked palm
oil production to reduced poverty and higher gross re-
gional product [27], and to positive effects on smallholder
income but also to increased inequality in palm oil farmer
contracts [28–30]. In addition, oil palm cultivation has
been shown to have significant positive effects on farmers’
livelihoods by increasing farm households’ consumption,
and by creating efficiencies in farming activities and sec-
ondary gains from the time saved on farm labour [31].
Modelling studies of palm oil include partial equilibrium
models which analyse how shifts in oil consumption pat-
terns affect palm oil consumption in high consuming
countries [32] and also include both global and single-
country general equilibrium models which analyse the po-
tential benefits of acceleration in oil palm yield growth in
Indonesia and Malaysia [33] and capture the benefits of
increased export taxes and higher world market prices for
palm oil on household welfare in Indonesia [34]. Other
multi-faceted modelling studies have employed a systems
dynamic modelling approach to capture environmental,
economic, social and human welfare perspectives of palm
oil policies [35] and another study examined health,
nutrition and economic aspects of oil palm adoption by
farmers using survey data and econometric models [36].
While the latter study analysed household living stan-
dards, nutrition, food and non-food expenditures, calorie
consumption and dietary quality, none of the aforemen-
tioned studies attempts to assess the health and macro-
economic burdens attributable to palm oil.
Broadening the scope beyond palm oil-specific studies,
economy-wide simulation studies of health policy scenar-
ios have been applied to assess adoption of healthy diet
regulations [37], infectious disease pandemics [38] and en-
vironmental issues with health impacts or co-benefits [39,
40]. Some CGE studies have used satellite epidemiological
models for infectious diseases [41–43] or nutrition mea-
sured through application of fixed caloric food coefficients
(but do not fully integrate the clinical health feedbacks to
the economy) [44, 45]. Also, one study linked satellite
models to a CGE model to form a comprehensive eco-
nomic, environmental, nutritional and clinical health
model framework for the EU [46] but this model does not
fully integrate a nutrient-related serum cholesterol bio-
marker health pathway as employed in this study. There-
fore, whilst there are studies which demonstrate the
usefulness of the CGE approach and whilst methodolo-
gies are moving towards full integration of health in
CGE models, including an integrated CGE disease bur-
den study for infectious disease [47], there are no dis-
ease burden studies which use fully integrated health
and macroeconomic models to assess non-communic-
able disease, or attempt to measure health and macro-
economic burdens for palm oil consumption.
Methods
In order to assess the health-related burden of palm
cooking oil consumption across the whole economy, we
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employ a sectoral macroeconomic approach, computable
general equilibrium (CGE) modelling. An important
methodological development for our disease burden as-
sessment is the full integration of a health modelling and
demographic modelling component within the CGE
model which together capture the cyclical feedback ef-
fects between the macro-economy, household consump-
tion, health and the population. A detailed specification
of the model and datasets is provided in [48], but a sum-
mary of its value and implementation is provided here.
Modelling health-related disease burdens
World Health Organisation (WHO) guidance has
highlighted the heterogeneous and disparate nature of
disease burden estimation methods across clinical,
epidemiological and economic perspectives. Even
within health economics, the benefits and shortcom-
ings of different approaches is elucidated: capturing
health-related productive labour supply effects and
macroeconomic impacts of demographic change is
highlighted as important, as is capturing income ef-
fects at the household level. However, whilst eco-
nomic, epidemiological and population indicators are
important, WHO guidance also highlights the import-
ance of distinguishing market and non-market costs
and caregiver time losses [49]. Satisfying so many ap-
parently exclusive goals would appear to require mul-
tiple tools and techniques but, as we shall show, it is
possible for a single tool to simultaneously address
them. The palm oil-focussed disease burden assess-
ment method, employed in this study, addresses many
of these apparently conflicting goals and perspectives
by fully integrating models of the macro-economy,
health and demographics in a single holistic model
framework. The model captures macroeconomic pro-
ductive labour supply effects, from patients and care-
givers, and health system costs (economic disease
burden), but also produces separate health indicators
relating to cases, deaths and caregiver losses (health-
related disease burden), and population level indica-
tors, and disaggregates all outputs at the household
level. Furthermore, by fully integrating the models, ra-
ther than running them in isolation, the disease bur-
den estimates also account for interactions and
feedback effects between health, the macro-economy
and the population. The omission of feedback effects
has been previously highlighted as a weakness in
macroeconomic modelling studies of pandemic influ-
enza disease burden simulations [50], and although
adjustments in the design of simulation scenarios to
account for feedback have been attempted elsewhere
[38, 51], this study constitutes the first disease burden
focussed study, of a non-communicable disease, based
on a fully integrated macroeconomic, health and
population model.
Furthermore, since this is the first non-communicable
disease burden estimation of its kind, context is provided
by performing additional analyses which use the same
model framework to estimate the total myocardial infarc-
tion (MI) and stroke health burden in the same country
context. Health modelling in the palm oil focussed simula-
tions also relates to MI and stroke. The country selected
for this analysis is Thailand, a major producer and con-
sumer of palm oil which not only focuses on domestic use
of the palm oil it produces but also regulates the formula-
tion of its biofuels to ensure priority of palm oil supply for
food use. The importance of palm oil to Thai diets, and
Thailand in general, makes it the ideal context for a
health-focussed disease burden assessment.
Macroeconomic modelling component
The CGE model, employed in this study, is a sectoral
mathematical model of the whole economy, which ex-
tends the fully documented IFPRI standard model [52].
The model captures the cost minimising and profit max-
imising behaviour of producers as well as consumption
and saving behaviour of households and government,
taxation mechanisms and the use of labour, capital and
other factors in order to produce goods and services for
investment or consumption. It also includes trade across
international borders. The specification of production
behaviour enables health-related labour changes, across
all sectors, to be captured and valued at a dynamic wage
level which adjusts, endogenously, according to eco-
nomic growth, and to expansion or contraction of sec-
tors in response to policy impacts over time. The
relevance of the dynamic, multi-sector, household level
modelling approach, and the CGE methodology itself, to
capture productive labour supply impacts and estimate
disease burdens, has been highlighted previously [49].
The CGE modelling process involves finding a bench-
mark solution (representing the current economy), and
then simulating shocks, such as the removal of disease
burdens to produce a new solution for comparison with
the benchmark in order to estimate the economic im-
pact of the simulated policy/event. This method has
been used previously with satellite health models [53].
Our CGE model is calibrated from a 2007 Thailand
Social Accounting Matrix (SAM) data set [54] and the
original 260 sectors were aggregated into 49 commod-
ities including 20 primary agricultural and food sectors.
The model distinguishes nine households by region and
urban/rural classification using data from the 2011
Household Socio-Economic Survey [55]. The CGE
model was further extended to include an Almost Ideal
Demand System (AIDS) specification of private demand
for each of our nine regional households, based on price
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and income elasticities derived from the literature [56]
with supplementary data from a recent Thai-specific
food demand system study [57] and additional (non-
Thai) edible oil cross-price elasticities [58, 59], to pro-
vide detail for primary agricultural and edible oil sectors,
documentation of which is available elsewhere [48].
Model integration
When modelling disease burdens from multiple perspec-
tives, interaction and feedback effects between those per-
spectives may be important. For example, the removal of
disease burdens through changes in food consumption
may produce health and demographic effects which feed
into labour supply and production affecting all sectors
and creating ripple effects throughout the economy for
income, savings and consumption. However, since these
ripple effects cannot be known in advance and since
consumption patterns will continue to affect health and
feedback effects over time, these impacts can only be
fully captured if economic, health and population im-
pacts are calculated, endogenously, as part of an inte-
grated simulation process. Whilst our model can be
used to employ policy instruments and/or for broader
non-health applications, we limit our integrated model
application, in this case, to simulate the macroeconomic,
health and demographic burden of changes in nutri-
tional intakes of households related to their consump-
tion of palm oil to mirror the replacement of palm
cooking oil with consumption of ‘other dietary oils’. By
this means, we isolate the disease-burden impact of palm
oil consumption.
The model integration we employ is illustrated in Fig. 1.
The central feature of the non-economic part of the model
is the inclusion of nutritional weights for food sectors, a
demographic model and polynomial approximations to
age- and gender-specific lookup tables derived from a mi-
cro-simulation health model to translate changes in nutri-
tional exposure to clinical health outcomes. As illustrated
in Fig. 1, changes in household-specific demands for food
commodities (including palm cooking oil) are multiplied by
nutritional weights in order to calculate the changes in the
nutritional profiles of household consumption (particularly
those relating to SFA, PUFA and MUFA). The changes in
the ratios of fatty acids consumed are translated to changes
in total-to-HDL cholesterol ratios using parameters from
the literature [4], and the changes in cholesterol biomarker
values are, subsequently, used to compute changes in clin-
ical health based on age- and gender-specific polynomials
linking cholesterol biomarker build-up to MI- and stroke-
related incidence and excess mortality rates. The health
model, adapted for this purpose, has been previously pub-
lished [6, 48]. Furthermore, the clinical health lookup ta-
bles, underlying the age- and gender-specific clinical health
polynomials, were derived from a simulated cohort of 10,
000 individuals for whom the mean and standard deviation
of total/HDL cholesterol ratio were taken from the Thai
National Health Examination Survey. Simulated incidence
numbers, and years lived with disability (YLD) weights from
the literature [60], are used to estimate morbidity impacts
and incidence rates. These are combined with Thailand-
specific average time loss estimates [61] and used to esti-
mate caregiver leisure and worktime losses. Incidence rates,
together with baseline unit costs for MI [62] and stroke
[63], are used to calculate healthcare costs. Finally, morbid-
ity, mortality and caregiver time losses are adjusted, using
Thailand-specific workforce participation rates [64], and ap-
plied in the demographic module to estimate changes in
productive labour supply, which are used as feedback ef-
fects into the macroeconomic model. More information on
the sub-models of the integrated framework is provided in
(Additional file 1: Appendix A) and full documentation is
available elsewhere [48].
Model scenario
The method employed in order to assess the health-re-
lated burdens associated with palm cooking oil consump-
tion in Thailand is a nutrient-matching scenario which
isolates the additional health, macroeconomic and popula-
tion impacts that result from consuming "palm cooking
oil" rather than “other dietary oils” (but assumes that there
were no cost or supply constraints to allow a direct re-
placement of palm with other dietary oils). In practice, the
nutrient-matching scenario involves changing the nutrient
coefficients for palm cooking oil to match those of other
types of edible oils. This approach does not use an eco-
nomic policy instrument to encourage replacement of
palm cooking oil with another edible oil, but mirrors a
‘magic bullet’ whereby the differences in nutritional prop-
erties of palm cooking oil, relative to other edible oils, are
instantly aligned without policy or intervention and where
no change in price or tax or other incentives are imposed
in order to accomplish the change, thus isolating the ‘pure
diet’ effect. The CGE model does adjust to capture the im-
pact of this shock: household food consumption quantities
will initially remain the same, but the changed nutritional
exposures will feed into the health model and result in
changes in total-to-HDL cholesterol ratios, and health
outcomes will filter through into the demographic model,
in the form of patient and caregiver-related productive
labour supply changes as shown in Fig. 1, which, together
with changes in healthcare expenditure, will feed back into
government and household budgets in the macroeco-
nomic model. The model will, subsequently, find a new
equilibrium which reflects the removal of the additional
burden of palm cooking oil on health and the economy,
relative to consumption of other edible oils. This burden
estimate represents the additional nutritional health
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and economic burden of household consumption of
palm cooking oil in Thailand over other oils but does
not prescribe a policy in order to remove it. Simula-
tions are run for 20 years (2016 to 2035) and expos-
ure changes are applied from the first year of
simulation. As such, our burden estimates do not
capture impacts from palm oil consumption in previ-
ous years, which may be realised in the current time
period, but only include those impacts which result
(and accumulate) from changes in palm oil consump-
tion during the 20-year time horizon of our simula-
tions. The 20-year timescale was selected as
sufficiently short to maintain reliability of estimation
whilst being long enough to allow accumulation of
workforce effects. We also employ an additional simu-
lation where palm oil nutritional coefficients are un-
changed but where the total excess health burden of
MI and stroke in Thailand (including patient and
caregiver-related productive labour supply changes
and changes in healthcare expenditure) are removed
from the counterfactual. The removal of excess health
burdens was possible since our clinical health lookup
tables translate changes in total-to-HDL cholesterol
ratio into changes in incidence and excess (rather
than total) mortality rates for MI and stroke. The en-
dogenous simulation of wage rates and healthcare
unit costs also ensures that the calculation of total
health benefits of illness elimination (the economic
disease burden) is model consistent and takes account
of future healthcare unit costs and labour market
feedback effects (see Additional file 1: Appendix A for
details about modelling of healthcare unit costs). This
estimate of the “total” disease burden provides a
methodologically consistent comparator for our nutri-
ent-matching scenario results. Finally, we explore the
impact of parameter uncertainty, related to the key
serum cholesterol biomarker health pathway parame-
ters from Mensink et al. [4], by utilising a previously
published Monte Carlo simulation methodology [65,
66] and adapting it for use in our Thailand CGE
model in order to produce sensitivity analyses of our
results. The procedure was based on 250 sets of inde-
pendent draws of SFA, MUFA and PUFA parameters
from normal distributions, with prior means and
standard deviations derived from Mensink et al. The
number of independent draws ensures that average
point estimates, for all outcome measures, have a pre-
cision of < 3.5 percentage points at the 95% confi-
dence level.
Results
Economic and health disease burden estimates from our
simulations are presented in Table 1. All of the eco-
nomic burden estimates in the table account for changes
in productive labour supply due to morbidity, mortality
Fig. 1 Model diagram. Diagram of integrated model framework
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or loss of caregiver time amongst working age employed
people, and for healthcare costs. The health indicators
which drive these burdens, including incidence and
deaths, are also reported.
Total disease burden results
The first column of Table 1 illustrates the impact of re-
moving the total disease burden attributable to stroke
and MI in Thailand. This burden consists of 1.7 million
MI cases and 2.1 million stroke cases resulting in an es-
timated 1 million MI deaths and 880,000 stroke deaths
in Thailand over our 20-year time horizon. The cumula-
tive economic impact of the total economic burden of
MI and stroke in Thailand, estimated in real gross do-
mestic product (GDP) terms, is approximately US$69bn
(Table 1), while dynamic population impacts range from
approximately 71,000 persons in 2016 up to 1.5 million
persons in 2035 (not shown). The trajectory is approxi-
mately linear. Removing this burden entirely is not
achievable as it would represent the complete removal of
MI and stroke in Thailand. However, estimating this
burden, using our integrated framework, provides a
helpful comparator for our palm cooking oil disease bur-
den simulation.
Nutrient matching results
The nutrient matching simulation results illustrate the
additional burden of household consumption of palm
cooking oil over and above the burden that would be
imposed by consumption of ‘other’ edible oils. The
central estimates of our confidence intervals indicate
that health burdens account for less than 0.5% of
total burden values and suggest that incidence of MI
and stroke would be expected to decline by 8280 and
2639 cases, respectively, and cumulative MI and
stroke deaths by 4683 and 894, respectively, if an ag-
gregate of other oils could be introduced, in a costless
way, to replace household consumption of palm
cooking oil over our 20-year time horizon (Table 1).
Vegetable oils contribute, on average, approximately
14% of Thai daily SFA energy intake, with variation
(from 11 to 19%) by region and urban/rural area (not
shown). The changes in disease burdens are driven by
the increased consumption share of PUFA (11.68% to
13.67% over the simulation period), slightly reduced
consumption share of MUFA (− 3.04% to − 3.00%
over the simulation period) and reduced consumption
share for SFA (− 6.84% to − 6.49% over the simulation
period). A further decomposition of changes in fatty
acid consumption in terms of Kcal changes is shown
in Fig. 2. These changes in exposure result in a linear
population-wide decline in average cumulative total-
to-HDL cholesterol ratio from 0.004 to 0.080 over the
simulation period (a decline of between 0.09 and
1.73% in the total-to-HDL cholesterol ratio). The size
of the economic disease burden is estimated to be
US$308mn, just under half of 1% of the total eco-
nomic burden and 0.003% of Thailand’s expected cu-
mulative GDP over our time horizon (not shown).
Consumption patterns differ between household types
and economic, health and population outcomes reflect
this. A decomposition of household impacts is provided in
Figs. 3, 4 and 5. In general, a transition away from house-
hold consumption of palm cooking oil towards other oils
would generate a larger reduction in disease burden (with
accompanying health benefits and population increase) in
urban than in rural areas, and population impacts accu-
mulate over time showing much larger population gains
in 2035 than in 2016. The Bangkok and Central regions
experience the largest benefits from the removal of disease
burdens. Southern, Northeast and Northern regions ex-
hibit similar reductions in disease burdens, although com-
paring these three regions amongst themselves, the
Southern region reductions in disease burden are margin-
ally larger for urban areas and more than twice as large
for rural areas. These differences by location and urban/
Table 1 Economic and clinical health burden results
Total MI/stroke burdens MI/stroke burdens from palm cooking oil (95% CI) % of total (95% CI)
Economic burden (mn USD)
Cumulative real GDP 69,488 308 (149, 467) 0.44% (0.22%, 0.67%)
Clinical health burdens (1000′)
Cumulative life-years lost 15,264 49.9 (24.2, 75.7) 0.33% (0.16%, 0.50%)
Cummulative incident cases
MI 1694 − 8.3 (− 12.6, − 4.0) 0.49% (0.24%, 0.74%)
Stroke 2058 − 2.6 (− 4.0, − 1.3) 0.13% (0.06%, 0.19%)
Cummulative deaths
MI 1023 − 4.7 (− 7.1, − 2.3) 0.46% (0.22%, 0.69%)
Stroke 880 − 0.9 (− 1.4, − 0.4) 0.10% (0.05%, 0.15%)
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rural categorisation reflect the higher levels of palm cook-
ing oil consumption in urban than rural areas and primar-
ily reflect differences in consumption and population size
by region. Consumption of palm cooking oil in the rural
South region, where the majority of palm cooking oil is
produced, is greater than in central and northern rural re-
gions and this is reflected in the disease burden estimates.
Tables to further illustrate the nutrient matching effects
with household disaggregation are shown in (Additional
file 1: Appendix B).
Figure 6 illustrates the dynamic trajectory of the eco-
nomic and health burdens. By consuming other oils in
place of palm cooking oil, the estimated number of MI
incident cases averted increases slowly over time from
approximately 330 to 490 per year in order to reach the
cumulative total of 8280. Stroke cases averted similarly
increase from 111 to 146 per year totalling 2639. The
corresponding annual real GDP impacts increase in
magnitude from US$160,000 in 2016 to US$36.4mn in
2035. Real (private) consumption, which encompasses all
Fig. 3 Changes in household population and deaths (persons). Disease burden impact on population and deaths by household
Fig. 2 Aggregate fatty acid intakes (Kcal). Aggregate energy and fatty acid consumption changes
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Thai consumption items including agricultural and proc-
essed foods, manufactures and all types of services in-
cluding medical services, is also shown. After an initial
decrease in the first year, real consumption rises annu-
ally from US$140,000 in 2017 to US$19.2m in 2035.
A decomposition of the cumulative patient and care-
giver time losses is also provided in Fig. 7. Caregiver
work-time lost (1785 person-years) is greater than pa-
tient work-time lost (1037 person-years). Leisure time
lost by caregivers does not contribute to the economic
burden but amounts to 3001 person-years over our 20-
year time horizon.
Sensitivity analysis
The sensitivity analyses of our nutrition matching simu-
lation results, to changes in key health model parame-
ters, are shown in Table 1 and Fig. 7. Table 1 shows that
the upper/lower cumulative burdens differ from the cen-
tral estimates by ± 50% giving a range for the clinical
health impacts of between 24 and 76 thousand cumula-
tive life-years lost and a range for the economic impact
of US$149mn to US$467mn. The dynamic results are
shown in Fig. 6 and, similar to the cumulative burdens,
the upper/lower values of the confidence intervals vary
from the central estimates by approximately ± 50% year
Fig. 4 MI and stroke disease burden by household. Disease burden, cases and deaths from MI and stroke by household
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on year. These sensitivity results illustrate that, whilst
the direction of effect is unaltered, the uncertainty of as-
sumptions, underlying our health model, can halve or
significantly magnify estimates of the health and macro-
economic burdens of palm cooking oil in Thailand.
Discussion
Our simulations illustrate the health-related eco-
nomic, disease and population burden of palm cook-
ing oil consumption in a high-consuming country
context, Thailand. In calculating these burdens, it is
acknowledged that substitution of palm oil with other
dietary oils may not be possible in all processed food
applications and some consumption of dietary oils is
unavoidable. However, by focussing on the burden at-
tributable to household consumption of palm cooking
oil in Thailand, and employing a nutrient matching
methodology, we isolate the ‘pure’ burden placed on
the Thailand economy and its population from palm
cooking oil consumption. As such, our analysis does
not allow for the changes in consumption patterns
that might result from policy instruments such as
taxes, subsidies or regulation. Any consumption
changes, outside the palm oil sector, result from the
health cost and productivity-related 0.003% expansion
in the Thai economy, only. These aggregate impacts
are small. Differential impacts, exhibited at the house-
hold level, are driven, primarily, by relative differences
Fig. 5 Household decomposition of fatty acid consumption. Changes in daily energy intake from fatty acid consumption by household
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in consumption patterns of palm cooking oil. How-
ever, the absence of distributional impacts across sec-
tors, and across food sectors in particular, confirms
that our estimates reflect the pure burdens relating to
consumption of palm cooking oil in isolation, and not
broader dietary change.
By using the same model framework to measure total
MI and stroke burdens from all causes, we find that palm
cooking oil burdens constitute approximately 0.5% of total
MI and stroke burdens, the magnitude of which varied by
± 50% under our sensitivity analyses. Since our nutrient
matching simulations assume no overall change in the
Fig. 6 Dynamic health and economic burden effects. Dynamic MI, stroke, GDP and real consumption effects with confidence intervals
Fig. 7 Patient and caregiver time losses. Patient and caregiver work and caregiver leisure time losses
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total amount of dietary oils consumed, they reflect only
the additional burden that, without changing diets, will
result from consumption of palm cooking oil in Thailand
over the next 20 years. Combined with the fact that our
burden estimates also isolate household consumption of
palm cooking oil from the use of palm oil in the processed
food sector, our results indicate that health-related disease
and economic burdens could be reduced by replacing con-
sumption of palm cooking oil with other oils. However,
the practicalities of removing the burden may result in
other consequences if they result in substitution in the
diet or require costly implementation.
Extrapolating from our results, it is reasonable to
assume that any burden from palm cooking oil con-
sumption in Thailand is likely to be present in a
similar proportion in other high consuming nations,
and consumption is known to be high in many coun-
tries in South and South East Asia. It is likely that
the broader implications of palm oil policies on eco-
nomic production and the environment will continue
to dominate the global debate, but the implications of
palm oil consumption on health may also warrant
consideration and influence policy recommendations.
In terms of methodology, the integrated modelling
approach, used to simulate these disease burdens, has
the strength of combining a multi-sector CGE model,
which comprehensively captures economic spill-overs,
interactions and wage effects to robustly value pro-
ductive labour, with other sub-models. The sectoral
nature of the CGE approach allows the full integra-
tion of a health sub-model to capture transmission
between consumption of food commodities and health
outcomes, the outputs of which are, in turn, fed into
a fully integrated demographic model. The resulting
model not only provides an important valuation of
economy-wide effects but also enables the decompos-
ition of different aspects, such as the health and
population burdens in a single general equilibrium
application. However, the complex nature of the
model means that detailed sectoral and household ag-
gregation is data intensive and limited. This has re-
sulted in aggregation of the processed food sector
where, although some substitution of palm oil may be
possible, the practicalities of reformulation and impact
on palatability cannot be captured, and this has par-
tially influenced our focus on household consumption
of dietary palm cooking oil. The health effects we
have captured relate changes in SFA, MUFA and
PUFA consumption to MI and stroke via changes in
the total-to-HDL cholesterol ratio, but additional ex-
posures and health conditions, which may be of rele-
vance, have been left for future consideration.
Sensitivity analyses of the key health parameters re-
sulted in ± 50% variations in disease burden impact
for upper and lower bounds of the 95% confidence
intervals. This demonstrates that the magnitudes of
burden estimates are sensitive to health parameter as-
sumptions, but provides a helpful estimate of the
range of burden estimates. One further limitation of
the results, presented, is that the ‘total disease bur-
den’ scenario specification, in this application, does
not produce the broader economic and environmental
impacts, which are likely to result from changes in oil
palm production patterns. These impacts could be
captured if a policy instrument was employed in the
simulation. Policy analysis is a strength of the CGE
framework, and an example of reducing palm oil con-
sumption using a sales tax has been published else-
where [48]. However, whilst the substitution effects
within an equilibrium model ensure realistic policy
simulations, they contaminate estimation of the pure
disease burden effect, which is the focus of this study.
Similarly, likely changes in land use, provoked by sub-
stitution away from palm oil, could, for example, be
an important consideration in this context, and could
also be captured in a policy-focussed study [48].
Conclusion
Our simulations indicate that consumption of palm cook-
ing oil, rather than other dietary oils, are associated with
negative health and economic burdens in Thailand, and, by
extension, in high consuming countries. Since our analysis
focuses on palm cooking oil, and assumes no overall reduc-
tion in dietary oil consumption, our burden estimates,
which constitute 0.5% of the total burdens of MI and
stroke, are an important indicator of the need for further
assessment of the implications of palm oil consumption.
Furthermore, we have demonstrated that development of
integrated sectoral model frameworks is possible and such
tools may be useful in assessing economic and health-re-
lated disease burdens. Further analyses, using similar tools,
to assess the potential impacts of the use of palm-oil in
other food applications and consideration of the implica-
tions of trade in palm cooking oil, would be highly relevant
to inform policy makers.
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